Implications of the review for practice and researchPractice: The authors suggested that as differences between timolol, prostamide and prostaglandin analogues are small, variables such as patient characteristics, quality of life, compliance and costs may be considered when deciding on starting therapy for primary open-angle glaucoma or ocular hypertension.